Chee Conley

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 86% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -88%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Chee Conley's trades of Syros Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
119.18
Quantity 32,718
Value US$1,734,901
Transaction date
Proposed sale
Price
22.12
Quantity 43,671
Value US$3,082,736
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-20 2024-11-18
S Sale
85,699 +14.3%
356.18
US$4,779,625 		85,699 +14.3% 356.18 US$4,779,625
2024-11-18 2024-11-18
PrS Proposed sale
32,718
119.18
US$1,734,901 		32,718 119.18 US$1,734,901
2024-11-18 2024-11-18
PrS Proposed sale
43,671
22.12
US$3,082,736 		43,671 22.12 US$3,082,736
2024-09-12 2024-09-11
B Purchase
50,000 +69.0%
1.71
US$85,420 		50,000 +69.0% 1.71 US$85,420
2024-09-12 2024-09-10
B Purchase
50,000 +222.2%
1.51
US$75,260 		50,000 +222.2% 1.51 US$75,260